For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
As of close of business last night, Coherus Biosciences Inc’s stock clocked out at $1.44, down -2.04% from its previous closing price of $1.47. In other words, the price has decreased by -$2.04 from its previous closing price. On the day, 2.35 million shares were traded. CHRS stock price reached its highest trading level at $1.6 during the session, while it also had its lowest trading level at $1.44.
Ratios:
To gain a deeper understanding of CHRS’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.09 and its Current Ratio is at 1.25.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, UBS on August 16, 2024, Downgraded its rating to Neutral and sets its target price to $1.50 from $4 previously.
On November 17, 2023, Robert W. Baird started tracking the stock assigning a Outperform rating and target price of $11.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CHRS now has a Market Capitalization of 165906720 and an Enterprise Value of 338092320. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.55. Its current Enterprise Value per Revenue stands at 1.111 whereas that against EBITDA is -2.892.
Stock Price History:
The Beta on a monthly basis for CHRS is 0.81, which has changed by -0.402439 over the last 52 weeks, in comparison to a change of 0.23147523 over the same period for the S&P500. Over the past 52 weeks, CHRS has reached a high of $2.97, while it has fallen to a 52-week low of $0.66. The 50-Day Moving Average of the stock is 12.61%, while the 200-Day Moving Average is calculated to be -4.28%.
Shares Statistics:
It appears that CHRS traded 5.02M shares on average per day over the past three months and 1912630 shares per day over the past ten days. A total of 115.21M shares are outstanding, with a floating share count of 110.59M. Insiders hold about 4.02% of the company’s shares, while institutions hold 66.10% stake in the company. Shares short for CHRS as of 1735603200 were 30715772 with a Short Ratio of 6.12, compared to 1732838400 on 30717116. Therefore, it implies a Short% of Shares Outstanding of 30715772 and a Short% of Float of 31.11.
